Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

June 23rd 2020, Crypto Chartbook: Success is when preparation meets opportunity

Success is when preparation meets opportunity Why screen exposure and overall experience is so needed in the field of trading is related to the fact that the market has a high degree of variability. It takes years to have seen at least a good part of the various things th...

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...

What Do These Three Charts Have in Common?

Bob Moriarty of 321gold provides three charts for readers. Hint: That's what massive tops look like. Don't tell anyone else, I want to keep it a secret between you and me. Bob Moriarty founded 321gold.com , with his late wife, Barbara Moriarty, more...

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...

A Historical Perspective on Silver

When we don't understand the present, we can turn to the past. It is believed the natural ratio in the earth's crust is ~10 ounces of silver for one ounce of gold. Back in 3000 BC in Mesopotamia (modern day Turkey, Iraq, Iran), silver and gold were used to enable trade ...

Azarga Gets Thumbs Up from Analysts After Favorable Ruling on NRC License

After receiving a favorable ruling on the NRC license, its focus shifts to project economics. Azarga Uranium Corp. (AZZ:TSX; AZZUF:OTCQB; P8AA:FSE) recently announced that the Atomic Safety and Licensing Board (ASLB) issued its Final Initial Decision, resolving the...

Gold Is Due a Correction

All markets go up. All markets go down. No market ever goes straight up unless it's the end of the world and in that case why would you care? Gold hit bottom in early 2016. Smart money was buying then. Gradually gold rose and fell with the tide until lately when it we...

Silver, Gold and Platinum Are Due a Break

When you are climbing the steepest of mountains, especially at high altitudes, it can be tiring. If you start getting a nosebleed, you are simply working too hard and need a break. The DSI (Daily Sentiment Index) on gold hit 97 four weeks ago and while it has struggled ...

Silver's Sharp Reaction Back

Technical analyst Clive Maund charts silver and explains why he believes it hasn't hit a final top. Silver reacted back sharply on Thursday and Friday after a parabolic blowoff top. This was not a final top, but it does indicate that silver needs to take a rest and co...

The Daily Sentiment Suggests a Major Market Top Is Near

As of November 18 th , sentiment for the S&P futures and the Nasdaq Index is approaching nosebleed territory. The infusion of hundreds of billions of dollars on the Fed's balance sheet since Mid-September has pumped the stock market higher in response. But no matter how...
1 2 3 4 5 6 7 8 9 10 ...